Real-time enrollment status for this chemotherapy-induced peripheral neuropathy (cipn) clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 8:05 PM UTC
| NCT Number | NCT07697560 |
| Recruiting Status | Recruiting |
| Condition | Chemotherapy-induced Peripheral Neuropathy (CIPN) |
| Phase | PHASE1 |
| Target Enrollment | 32 participants |
| Active Locations | 1 sites in the US |
| Sponsor | AnHorn Medicines Co. Ltd. |
| Last Updated on CT.gov | July 29, 2026 (Jul 29, 2026) |
As of September 1, 2026: Clinical trial NCT07697560 is currently recruiting participants. This phase1 study for chemotherapy-induced peripheral neuropathy (cipn) is actively seeking new participants at 1 location across the United States. The study is sponsored by AnHorn Medicines Co. Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07697560 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07697560 was last updated Jul 29, 2026 (July 29, 2026). HelloStudys verifies this status automatically.